Introduction: Diagnosis of the chronic inflammatory bowel diseases relies upon initial
recognition of an inflammatory condition, followed by definitive endoscopic, histological and …

Introduction: Traditional diagnosis and classification of inflammatory bowel diseases (IBDs)
have been based on clinical evaluation, laboratory testing, endoscopy, imaging, and …

Diagnostics of inflammatory bowel diseases (IBDs) currently relies on a combination of
biological and morphological tests. The current method of diagnostic remains a critical …

Diagnosis and prognosis of inflammatory bowel disease (IBD)—a chronic inflammation that
affects the gastrointestinal tract of patients—are challenging, as most clinical symptoms are …

There is currently no gold standard test for the diagnosis of inflammatory bowel disease
(IBD). Physicians must rely on a number of diagnostic tools including clinical and …

There is increasing importance placed upon noninvasive assessment of gut inflammation.
These tools are likely to be the key in differentiating intestinal inflammatory disease from …

Objective. There is increasing knowledge of the pathophysiology behind inflammatory bowel
disease (IBD) although the exact mechanism is far from fully understood. In the era of new …

The nonspecific inflammatory bowel diseases (IBD) represent a heterogeneous group of
chronic inflammatory disorders of the gastrointestinal tract, and Leśniowski‐Crohn's disease …

Unambiguous diagnosis of the two main forms of inflammatory bowel diseases (IBD):
Ulcerative colitis (UC) and Crohn's disease (CD), represents a challenge in the early stages …

In recent years the use of faecal and serologic biomarkers has been evaluated in the
diagnosis and management of inflammatory bowel disease (IBD). Faecal calprotectin (FC) …